Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U... Show more
HROW is expected to report earnings to fall 22.42% to 18 cents per share on November 17
Q3'25
Est.
$0.19
Q2'25
Beat
by $0.23
Q1'25
Missed
by $0.56
Q4'24
Beat
by $0.11
Q3'24
Missed
by $0.07
The last earnings report on August 11 showed earnings per share of 23 cents, beating the estimate of 0 cents. With 1.14M shares outstanding, the current market capitalization sits at 1.48B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HROW showed earnings on August 11, 2025. You can read more about the earnings report here.